Welcome Guest

Table of Contents

Volume 5 |  Issue 6

Publication Date: September 2007
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
359-361
Metastatic Renal Cell Carcinoma: Role of Mammalian Target of Rapamycin Inhibitors
Ronald M. Bukowski
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
362-370
Highlights from: The 43rd Annual Meeting of the American Society of Clinical Oncology; June 1-5, 2007; Chicago, IL
Manisha Gupta, Erin Grothey, Ronald Bukowski, Oliver Sartor
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
371-378
Combined Androgen Blockade in Advanced Prostate Cancer: Looking Back to Move Forward
Gerald Chodak, Leonard Gomella, De H. Phung
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
379-385
Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma
Daniel Cho, Sabina Signoretti, Sandra Dabora, Meredith Regan, Apryle Seeley, Mauro Mariotti, Amanda Youmans, Adam Polivy, Lucy Mandato, David McDermott, Eric Stanbridge, Michael Atkins
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
386-389
Long-Term Follow-up of Intravesical Bacillus Calmette-Guérin Treatment for Superficial Transitional-Cell Carcinoma of the Bladder Involving the Prostatic Urethra
Jonathan Harris Taylor, John Davis, Paul Schellhammer
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
390-396
Continuing Benefit of Zoledronic Acid in Preventing Skeletal Complications in Patients with Bone Metastases
Fred Saad, Yin-Miao Chen, Donald M. Gleason, Joseph Chin
  • Abstract
  • No Access
  • Add to Cart
Brief Communication
Page Number of this Article in the Print Version
397-400
Incidence and Clinical Course of Hemorrhagic Radiation Proctitis After Iodine-125 Prostate Brachytherapy
Mark V. Mishra, Reza Shirazi, William L. Barrett
  • Abstract
  • No Access
  • Add to Cart
Case Reports
Page Number of this Article in the Print Version
401-402
Complete Remission of Metastatic Carcinoma of the Prostate with Bicalutamide Withdrawal
Madappa N. Kundranda, Alaa Muslimani, Hamed A. Daw, Timothy P. Spiro
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
403-405
Persistent Hypocalcemia Induced by Zoledronic Acid in a Patient with Androgen-Independent Prostate Cancer and Extensive Bone Metastases
James L. Gulley, Shenhong Wu, Philip M. Arlen, William L. Dahut
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
406-408
A Second Transient Prostate-Specific Antigen Elevation After External-Beam Radiation Therapy and Fractionated Magnetic Resonance Imaging–Guided High-Dose Rate Brachytherapy Boost
Mark V. Mishra, Anurag K. Singh
  • Abstract
  • No Access
  • Add to Cart
Clinical Commentary
Page Number of this Article in the Print Version
409-412
Clinical Presentation and Outcome of Bladder Schistosoma–Unrelated Squamous Cell Carcinoma: Report on 33 Consecutive Cases
Ben Slama Mohamed Riadh, Rabii El Atat, Mohamed Sfaxi, Amine Derouiche, Nadia Kourda, Mohamed Chebil
  • Abstract
  • No Access
  • Add to Cart
Clinical Trials
Page Number of this Article in the Print Version
413
Selected Clinical Trials in Prostate, Renal Cell, and Bladder Cancer
CIG Media Group
  • Abstract
  • No Access
  • Add to Cart